Clearstead Advisors, LLC Medtronic PLC Transaction History

Clearstead Advisors, LLC

  • $6.31 Billion
  • Q3 2024

A detailed history of Clearstead Advisors, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Clearstead Advisors, LLC holds 38,718 shares of MDT stock, worth $3.14 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
38,718
Previous 21,275 81.99%
Holding current value
$3.14 Million
Previous $1.67 Million 108.18%
% of portfolio
0.06%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$76.84 - $91.03 $1.34 Million - $1.59 Million
17,443 Added 81.99%
38,718 $3.49 Million
Q2 2024

Aug 09, 2024
BUY
$78.71 - $87.02 $733,104 - $810,504
9,314 Added 77.87%
21,275 $1.67 Million
Q1 2024

May 14, 2024
SELL
$82.84 - $88.09 $462,164 - $491,454
-5,579 Reduced 31.81%
11,961 $1.04 Million
Q4 2023

Feb 12, 2024
SELL
$69.43 - $83.43 $98,243 - $118,053
-1,415 Reduced 7.47%
17,540 $1.44 Million
Q3 2023

Nov 13, 2023
SELL
$78.22 - $90.4 $105,675 - $122,130
-1,351 Reduced 6.65%
18,955 $1.49 Million
Q3 2023

Nov 07, 2023
BUY
$78.22 - $90.4 $88,466 - $102,242
1,131 Added 5.9%
20,306 $1.59 Million
Q2 2023

Aug 07, 2023
BUY
$79.47 - $91.38 $102,436 - $117,788
1,289 Added 7.21%
19,175 $1.69 Million
Q1 2023

May 09, 2023
SELL
$76.72 - $87.58 $85,389 - $97,476
-1,113 Reduced 5.86%
17,886 $1.44 Million
Q4 2022

Feb 14, 2023
SELL
$76.18 - $87.74 $124,859 - $143,805
-1,639 Reduced 7.94%
18,999 $1.48 Million
Q3 2022

Nov 14, 2022
BUY
$80.75 - $95.31 $646 - $762
8 Added 0.04%
20,638 $1.67 Million
Q2 2022

Aug 12, 2022
SELL
$87.4 - $113.09 $89,672 - $116,030
-1,026 Reduced 4.74%
20,630 $1.85 Million
Q1 2022

May 04, 2022
BUY
$100.58 - $112.38 $695,309 - $776,882
6,913 Added 46.89%
21,656 $2.4 Million
Q4 2021

Feb 14, 2022
BUY
$99.53 - $127.75 $66,486 - $85,337
668 Added 4.75%
14,743 $1.53 Million
Q3 2021

Nov 12, 2021
SELL
$122.75 - $135.17 $99,673 - $109,758
-812 Reduced 5.45%
14,075 $1.76 Million
Q2 2021

Aug 12, 2021
BUY
$118.19 - $131.5 $73,986 - $82,319
626 Added 4.39%
14,887 $1.85 Million
Q1 2021

May 14, 2021
BUY
$111.18 - $119.74 $39,246 - $42,268
353 Added 2.54%
14,261 $1.69 Million
Q4 2020

Feb 11, 2021
BUY
$100.57 - $117.14 $116,158 - $135,296
1,155 Added 9.06%
13,908 $1.63 Million
Q3 2020

Nov 12, 2020
SELL
$90.13 - $108.78 $34,880 - $42,097
-387 Reduced 2.95%
12,753 $1.33 Million
Q2 2020

Aug 11, 2020
SELL
$84.11 - $103.33 $18,251 - $22,422
-217 Reduced 1.62%
13,140 $1.21 Million
Q1 2020

May 14, 2020
SELL
$72.92 - $121.3 $23,334 - $38,816
-320 Reduced 2.34%
13,357 $1.21 Million
Q4 2019

Feb 11, 2020
BUY
$104.49 - $114.54 $39,601 - $43,410
379 Added 2.85%
13,677 $1.55 Million
Q3 2019

Nov 12, 2019
SELL
$98.02 - $111.18 $28,621 - $32,464
-292 Reduced 2.15%
13,298 $1.44 Million
Q2 2019

Aug 08, 2019
SELL
$84.15 - $99.38 $99,297 - $117,268
-1,180 Reduced 7.99%
13,590 $1.32 Million
Q1 2019

May 14, 2019
SELL
$82.45 - $93.79 $30,671 - $34,889
-372 Reduced 2.46%
14,770 $1.35 Million
Q4 2018

Feb 11, 2019
BUY
$85.8 - $99.49 $193,393 - $224,250
2,254 Added 17.49%
15,142 $1.38 Million
Q3 2018

Nov 13, 2018
BUY
$85.91 - $99.17 $58,161 - $67,138
677 Added 5.54%
12,888 $1.27 Million
Q2 2018

Aug 07, 2018
SELL
$77.48 - $87.83 $59,427 - $67,365
-767 Reduced 5.91%
12,211 $1.05 Million
Q1 2018

May 14, 2018
BUY
$76.55 - $87.26 $55,422 - $63,176
724 Added 5.91%
12,978 $1.04 Million
Q4 2017

Feb 09, 2018
BUY
$76.93 - $83.5 $12,462 - $13,527
162 Added 1.34%
12,254 $990,000
Q3 2017

Nov 09, 2017
BUY
$77.71 - $84.6 $939,669 - $1.02 Million
12,092
12,092 $940,000

Others Institutions Holding MDT

# of Institutions
2,288
Shares Held
1.02B
Call Options Held
8.05M
Put Options Held
7.19M
View Full List

About Medtronic plc

MDT Quotes by TradingView
  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email